| 1 |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| 2 |
Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040[J]. Transl Oncol, 2021, 14(10): 101174.
|
| 3 |
郭兰伟, 张兴龙, 蔡林, 等. 全球结直肠癌流行和防控现状[J]. 中华肿瘤杂志, 2024, 46(1): 57-65.
|
| 4 |
Tie J, Cohen JD, Lahouel K, et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage Ⅱcolon cancer[J]. N Engl J Med, 2022, 386(24): 2261-2272.
|
| 5 |
Ullah F, Pillai AB, Omar N, et al. Early-onset colorectal cancer: current insights[J]. Cancers, 2023, 15(12):3202.
|
| 6 |
Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review[J]. JAMA, 2021, 325(7): 669-685.
|
| 7 |
Ganesh K, Stadler ZK, Cercek A, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(6): 361-375.
|
| 8 |
Wan J, Zhao J, Fang X. Dynamics of the immune microenvironment and immune cell PANoptosis in colorectal cancer: recent advances and insights[J]. Front Immunol, 2024, 15: 1502257.
|
| 9 |
Zhou W, Jia Y, Liu Y, et al. Tumor microenvironment-based stimuli-responsive nanoparticles for controlled release of drugs in cancer therapy[J]. Pharmaceutics, 2022, 14(11): 2346.
|
| 10 |
Zhou T, Xie S, Zhou C, et al. All-in-one second near-infrared light-responsive drug delivery system for synergistic chemo-photothermal therapy[J]. ACS Appl Bio Mater, 2022, 5(8): 3841-3849.
|
| 11 |
Liu D, Ling Y, Dong L, et al. Ultrasound-triggered drug-loaded nanobubbles for enhanced T cell recruitment in cancer chemoimmunotherapy[J]. Biomaterials, 2025, 317: 123086.
|
| 12 |
Wang P, Chen J, Zhong R, et al. Recent advances of ultrasound-responsive nanosystems in tumor immunotherapy[J]. Eur J Pharm Biopharm, 2024, 198: 114246.
|
| 13 |
Ji C, Si J, Xu Y, et al. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation[J]. Theranostics, 2021, 11(17): 8587-8604.
|
| 14 |
庄帆, 李翠仙, 黄备建. 声动力疗法的研究进展[J]. 中华超声影像学杂志, 2020, 29(9): 819-823.
|
| 15 |
Zhou LQ, Li P, Cui XW, et al. Ultrasound nanotheranostics in fighting cancer: Advances and prospects[J]. Cancer Lett, 2020, 470: 204-219.
|
| 16 |
Cao Y, Chen Y, Yu T, et al. Drug release from phase-changeable nanodroplets triggered by low-intensity focused ultrasound[J]. Theranostics, 2018, 8(5): 1327-1339.
|
| 17 |
Hornsby TK, Kashkooli FM, Jakhmola A, et al. Kinetic modelling of ultrasound-triggered chemotherapeutic drug release from the surface of gold nanoparticles[J]. Sci Rep, 2023, 13(1): 21301.
|
| 18 |
Fan CH, Ho YJ, Lin CW, et al. State-of-the-art of ultrasound-triggered drug delivery from ultrasound-responsive drug carriers[J]. Expert Opin Drug Deliv, 2022, 19(8): 997-1009.
|
| 19 |
Batchelor D, Abou-Saleh RH, Coletta PL, et al. Nested Nanobubbles for Ultrasound-Triggered Drug Release[J]. ACS Appl Mater Interfaces, 2020, 12(26): 29085-29093.
|
| 20 |
Guo J, Pan X, Wu Q, et al. Bio-barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy[J]. Signal Transduct Target Ther, 2025, 10(1): 137.
|
| 21 |
Sun M, Yue T, Wang C, et al. Ultrasound-Responsive Peptide Nanogels to Balance Conflicting Requirements for Deep Tumor Penetration and Prolonged Blood Circulation[J]. ACS Nano, 2022, 16(6): 9183-9194.
|
| 22 |
SNipstad S, Vikedal K, Maardalen M, et al. Ultrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicine[J]. Adv Drug Deliv Rev, 2021, 177: 113847.
|
| 23 |
Liu K, Jing B, Kang J, et al. Ultrasound-Enabled Nanomedicine for Tumor Theranostics[J]. Engineering, 2025, 46(3): 101-129.
|
| 24 |
Zhu P, Chen Y, Shi J. Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation[J]. ACS Nano, 2018, 12(4): 3780-3795.
|
| 25 |
田慧敏, 程文. 影响声动力疗法抗肿瘤疗效的因素分析[J/OL]. 中华医学超声杂志(电子版), 2023, 20(8): 871-874.
|
| 26 |
Shen M, Wang Y, Zhang L, et al. Ultrasound-Triggered cascade delivery via poly-oxaliplatin nanoparticles for immunotherapy[J]. Adv Funct Mater, 2025, 35(34): 2425565.
|
| 27 |
Navarro-Becerra JA, Borden MA. Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy[J]. Pharmaceutics, 2023, 15(6): 1625.
|
| 28 |
Chen M, Liang X, Gao C, et al. Ultrasound triggered conversion of porphyrin/camptothecin-fluoroxyuridine triad microbubbles into nanoparticles overcomes multidrug resistance in colorectal cancer[J]. ACS Nano, 2018, 12(7): 7312-7326.
|
| 29 |
Zhang J, Sun L, Jiang L, et al. Regulation of CTLs/Tregs via Highly Stable and Ultrasound-Responsive Cerasomal Nano-Modulators for Enhanced Colorectal Cancer Immunotherapy[J]. Adv Sci (Weinh), 2024, 11(22): e2400485.
|
| 30 |
Cui R, Zhou J, Yang W, et al. Ultrasound-Triggered Nanogel Boosts Chemotherapy and Immunomodulation in Colorectal Cancer[J]. ACS Appl Mater Interfaces, 2025, 17(1): 211-221.
|
| 31 |
Beik J, Shiran MB, Abed Z, et al. Gold nanoparticle-induced sonosensitization enhances the antitumor activity of ultrasound in colon tumor-bearing mice[J]. Med Phys, 2018, 45(9): 4306-4314.
|
| 32 |
Wang ZH, Zeng X, Zhang S, et al. Acoustic-Magnetic Responsive Nanomotor Augments Oral Drug Delivery by Gastrointestinal Site Navigation and Mucus Layer Penetration[J]. ACS Nano, 2025, 19(18): 17228-17246.
|
| 33 |
张安妮, 余皙娟, 刘治军. 声动力疗法联合仿生药物递送系统的抗肿瘤研究进展[J/OL]. 中华医学超声杂志(电子版), 2024, 21(7): 737-740.
|
| 34 |
Li J, Yang R, Yuan Y, et al. An oral nanovaccine secreted by genetically engineered and ultrasound-responsive bacteria for colon cancer immunotherapy[J]. Adv Funct Mater, 2025, 35(6): 2414994.
|
| 35 |
Fan Y, Ye J, Kang Y, et al. Biomimetic piezoelectric nanomaterial-modified oral microrobots for targeted catalytic and immunotherapy of colorectal cancer[J]. Sci Adv, 2024, 10(19): eadm9561.
|
| 36 |
Huang S, Ding D, Lan T, et al. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis[J]. Acta Biomater, 2023, 164: 538-552.
|
| 37 |
Xu H, Zheng M, Ye D, et al. Ultrasound-triggered activation of p-azidobenzyloxycarbonyl-based prodrugs via radical-mediated cascade elimination[J]. J Am Chem Soc, 2025, 147(24): 20667-20679.
|
| 38 |
Emons G, Spitzner M, Reineke S, et al. Chemoradiotherapy resistance in colorectal cancer cells is mediated by wnt/β-catenin signaling[J]. Mol Cancer Res, 2017, 15(11): 1481-1490.
|
| 39 |
Yan L, Gao S, Shui S, et al. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro[J]. Int J Biol Macromol, 2020, 162: 1303-1310.
|
| 40 |
Liang R, Lin F, Mo X, et al. Orally Deliverable Engineered Porphyrin Nanohybrids Activate the cGAS-STING Axis and Enable Fusobacterium-Specific Targeting for Robust Immune Remodeling and Colorectal Cancer Regression[J]. ACS Appl Mater Interfaces, 2025, 17(36): 50237-50251.
|
| 41 |
Bakhshizadeh M, Moshirian T, Esmaily H, et al. Sonophotodynamic therapy mediated by liposomal zinc phthalocyanine in a colon carcinoma tumor model: Role of irradiating arrangement[J]. Iran J Basic Med Sci, 2017, 20(10): 1088-1092.
|
| 42 |
Qu X, Yin F, Pei M, et al. Modulation of Intratumoral Fusobacterium nucleatum to Enhance Sonodynamic Therapy for Colorectal Cancer with Reduced Phototoxic Skin Injury[J]. ACS Nano, 2023, 17(12): 11466-11480.
|
| 43 |
Li C, Luo Y, Huang L, et al. A hydrogen sulfide-activated Pd@Cu2O nanoprobe for NIR-Ⅱ photoacoustic imaging of colon cancer and photothermal-enhanced ferroptosis therapy[J]. Biosens Bioelectron, 2025, 268: 116906.
|
| 44 |
Zhang W, Wang J, Su L, et al. Activatable nanoscale metal-organic framework for ratiometric photoacoustic imaging of hydrogen sulfide and orthotopic colorectal cancer in vivo[J]. Sci. China Chem, 2020, 63(9):1315-1322.
|